Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
13 Novo Nordisk resubmitted Wegovy for a heart failure with preserved ejection fraction indication in early 2025 with an FDA decision originally anticipated in the second half of 2025, subsequently delayed into 2026
Semaglutide, a glucagon-like peptide-1 receptor agonist, has been extensively studied in numerous trials and consistently demonstrated its efficacy in reducing blood glucose levels and promoting weight loss
Other important safety information Do not use GLP-1s if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis
Ask a member of your care team for a referral or call the number above to make an appointment
Nutrition Considerations: What to Eat When Appetite Suppression Is Severe Strong appetite suppression is the goal of tirzepatide therapy, but it means you must eat strategically to avoid nutrient deficiencies
US$ 27.53
US$ 27.90
US$ 24.23
